Bristol-Myers Squibb Company
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
Last updated:
Abstract:
The present invention provides compounds of Formula (I): ##STR00001## or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
Status:
Grant
Type:
Utility
Filling date:
21 May 2020
Issue date:
6 Apr 2021